SCHEMBL784642

SCHEMBL784642

Cc1ccc(NC(=O)NC2CCCc3ccc(C(=O)N(C)C4CCN(c5ccncc5)CC4)cc32)cc1Cl

nearest known ligand 0.46

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
TRPV1 Q8NER1 1/20 0.46
NPC1 O15118 2/20 0.41
TSHR P16473 1/20 0.41
HTT P42858 1/20 0.41
RAB9A P51151 1/20 0.41
SMN1; SMN2 Q16637 1/20 0.41
EPHX2 P34913 1/20 0.41
KMT2A Q03164 3/20 0.40
ALDH1A1 P00352 3/20 0.40
LMNA P02545 2/20 0.40
CCNC P24863 1/20 0.39
CDK8 P49336 1/20 0.39
SLC2A1 P11166 3/20 0.38
CTSS P25774 2/20 0.38
MAPK1 P28482 1/20 0.38
MALT1 Q9UDY8 1/20 0.37
MEN1 O00255 1/20 0.37
MAPT P10636 1/20 0.37
F10 P00742 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL784419 0.93 TRPV1 (0.47) TRPV1NPC1KMT2AALDH1A1LMNA
SCHEMBL785926 0.90 TRPV1 (0.42) TRPV1NPC1KMT2AALDH1A1LMNA
SCHEMBL785738 0.90 ALDH1A1 (0.45) TRPV1NPC1TSHRRAB9AEPHX2
SCHEMBL785131 0.88 TRPV1 (0.42) TRPV1SMN1; SMN2KMT2AALDH1A1LMNA
SCHEMBL785511 0.87 TAS1R3 (0.52) TRPV1SMN1; SMN2KMT2AALDH1A1LMNA
SCHEMBL785701 0.87 TAS1R3 (0.41) TRPV1NPC1RAB9AKMT2ALMNA
SCHEMBL785349 0.87 NPC1 (0.39) NPC1TSHRHTTRAB9ASMN1; SMN2
SCHEMBL785726 0.87 TAS1R3 (0.41) TRPV1SMN1; SMN2KMT2ALMNACTSS
SCHEMBL784092 0.86 CCNC (0.42) TRPV1NPC1TSHRHTTRAB9A
SCHEMBL784618 0.86 TAS1R3 (0.45) TRPV1SMN1; SMN2KMT2AALDH1A1CTSS

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8680159-B2 Bradykinin 1 receptor modulating compounds GRUENENTHAL GMBH (DE) 2014-03-25 US claimed
US-20120071461-A1 Substituted Benzamide Compounds GRUENENTHAL GMBH (DE) 2012-03-22 US claimed
US-8680159-B2 Bradykinin 1 receptor modulating compounds GRUENENTHAL GMBH (DE) 2014-03-25 US disclosed
US-20120071461-A1 Substituted Benzamide Compounds GRUENENTHAL GMBH (DE) 2012-03-22 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120071461-A1 Substituted Benzamide Compounds BDKRB1, BDKRB2, HRH2 TRPV1 21/4885NPC1 2033/4885TSHR 586/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.